SNM member David James Brooks receives 2005 Kuhl-Lassen Award for research in brain imaging
Highest award from SNM and Society's Brain Imaging Council goes to pioneer in applying PET to movement disorders
TORONTO, Canada--Society of Nuclear Medicine member David James Brooks, M.D., D.Sc., FRCP, F.Med.Sci., is the recipient of the 2005 Kuhl-Lassen Award. SNM and its Brain Imaging Council present the award to scientists who have made significant contributions to the field of functional brain imaging using single photon emission computed tomography (SPECT) and positron emission tomography (PET). The Brain Imaging Council of the Society of Nuclear Medicine (SNM) presented the award on June 19 at the SNM's 52nd Annual Meeting in Toronto, Canada.
Brooks is the Hartnett professor of neurology with the PET Neurosciences Group, division of neuroscience and psychological medicine, at Imperial College School of Medicine (Hammersmith campus) in the United Kingdom. He delivered the Kuhl-Lassen Award Lecture at the 52nd Annual Meeting of the Society of Nuclear Medicine June 19 at the Metro Toronto Convention Centre and spoke on "Applications of Imaging to Movement Disorders: A View from the Frontier." A pioneer in the clinically informed application of PET to the field of movement disorders, Brooks has done truly groundbreaking studies in Parkinson's and related disorders using neuroimaging techniques to gain an improved understanding of the pathophysiology of those disorders. Brooks's research includes information about the progression of disease, primary mechanisms of onset and progression, differential diagnosis and the role of imaging to enhance the development of next-generation therapeutics in movement disorders.
A senior clinical scientist, Brooks's main research interests are functional imaging (both PET and functional MRI) and movement disorders. Over the past years, he and his research team have used functional imaging to investigate functional anatomy underlying motor tasks, the effects of pharmacological manipulations and behavior on brain dopamine release in healthy subjects and patients with movement disorders; the pharmacological and brain activation changes associated with onset, progression and treatment complications of Parkinson's and Huntington's diseases; and the effects of putative neuroprotective and restorative therapies in those diseases.
"I am extremely honored to be named the recipient of the Kuhl-Lassen Award by the Society of Nuclear Medicine," said Brooks. "Both David Kuhl's and Nils Lassen's work has had a great influence on my career, and I am delighted to accept an award bearing their names," he said. " I would also like to thank Drs. Terry Jones, Richard Frackowiak and David Marsden, who have all been seminal in shaping my career, and my wife Gill for her unswerving support throughout my research," added Brooks.
The highest award of SNM's Brain Imaging Council was created to honor two founding pioneers in functional brain imaging: SNM member David E. Kuhl, M.D., and the late Nils Lassen. The Kuhl-Lassen Award is given annually to recognize a scientist whose research in and service to the discipline of functional brain imaging is of the highest caliber.
Source: Eurekalert & others
Published on PsychCentral.com. All rights reserved.